期刊文献+

肺炎支原体BALB/c小鼠支气管肺泡灌洗液中IFN-γ、IL-4、IL-5、IL-10表达和气道阻力的变化 被引量:8

The alteration of IFN-γ,IL-4,IL-5 and IL-10 expressions in bronchoalveolar lavage fluid and airway resistance in mycoplasma pneumoniae infected BALB/c mice
原文传递
导出
摘要 目的通过建立肺炎支原体(MP)感染BALB/c小鼠的模型,探讨MP感染后小鼠支气管肺泡灌洗液(BALF)中炎性因子(IFN-γ和IL-4、IL-5和IL-10)的含量变化及其对气道阻力的影响。方法 50只BALB/c小鼠随机分为MP感染组(MP组)和PBS对照组(N组),每组25只,分别于接种后第3d、7d、14d、21d和30d从各组中取5只鼠,取肺脏制作病理切片,HE染色观察病理组织学变化;RT-PCR对模型进行鉴定;ELISA试剂盒检测BALF中IFN-γ、IL-4、IL-5和IL-10含量;同时用肺功能仪测定各组小鼠肺的吸气阻力、呼气阻力和顺应性。结果 MP感染小鼠后IFN-γ、L-4、IL-5和IL-10的含量较N组明显升高(<0.05);吸气阻力、呼气阻力较N组增加(<0.05),顺应性降低较N组增加(<0.05),第7天时达高峰,随后下降30天恢复正常。结论 MP感染BALB/c小鼠后气道阻力增加、顺应性降低,炎性因子过表达。 Objective To establish mycoplasma pneumoniae(MP) infected BALB/c mice model to explore the expression of inflammatory cytokines (IFN-γ and IL-4, IL-5 and IL-10) in bronchoalveolar lavage fluid(BALF) and the change of airway resistance in MP BALB/c mice. Methods 50 BALB/c mice were randomly divided into: MP infection group and PBS control group averagely. HE staining and RT-PCR were used to identify the histological changes and the model respectively, ELISA kit to detect the expression of IFN-γ, IL-4, IL-5 and IL-10; the inspiratory resistance, expiratory resistance and compliance were determined with spirometer. Results The expression levels of IFN-γ, L-4, IL-5 and IL-10 in bronchoalveolar lavage fluid were significantly higher in MP infected mice than in PBS control mice( P 〈0.05); the inspiratory resistance and expiratory resistance increased, but compliance decreased in MP infected mice than in PBS control mice(P 〈0.05), reached peak 7 days and then declined to normal 30 days after infection. Conclusion The airway inflammatory factors overexpressed in BALF, airway resistance increased, compliance decreased in MP infected BALB/c mice.
出处 《解剖科学进展》 CAS 2014年第3期240-245,共6页 Progress of Anatomical Sciences
基金 辽宁省自然科学基金(No.2013021020)
关键词 肺炎支原体 BALB C小鼠 炎性因子 气道阻力 inferior hypothermy cerebral ischemia-reperfusion PLC- γ1 SD rat
  • 相关文献

参考文献20

  • 1Sree M, Pemira, Robert W, et al. Mycoplasma pneumoniac infection presenting as bullous papular purpuric gloves and seeks syndrome: novel association and review of the literature[j]. Clinical Pediatrics, 2011, 50: 1140-1143. 被引量:1
  • 2Dimitrios A, Beth P, Frank R, et al. Diverse seizure presentation of acute mycoplasma pneumoniae encephalitis resolving with immunotherapy[j]. J Child Neurol, 2013, 10:1177-1180. 被引量:1
  • 3Zhi YO, Rong Z, Feng HW, et al. Retrospective analysis of mycoplasma pneumoniac infection in podiatric fatal pneumonia in guangzhou[j]. South China. Clinical Pediatrics, 2008, 47: 791-796. 被引量:1
  • 4Cheng ML, Li G, Sbeo JY, et al. Age-specfllc mycoplasma pneumoniac pneumonia-associated myocardial damage in children[J]. J Internat Med Res, 2013, 41: 1716-1723. 被引量:1
  • 5Nazima N, Randeep G, Sanjay K, et al. Mycoplasma pneumoniac and its role in asthma[j]. Postgrad Med J, 2007, 83: 100--104. 被引量:1
  • 6Guilbert TW, Denliager LC. Role of infection in the development and exacerbation of asthma[j]. Export Rev Respir bted, 2010, 4(1): 71- 83. 被引量:1
  • 7Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of Mycoplasma pnenmoniac infections[J]. Future Microbiol, 2008, 3(6): 635-648. 被引量:1
  • 8Jaythoon H, Fiona I, Soamus D, et al. Mycoplasmapneumoniae infection in a podiatric population: Analysis of soluble immune markers as risk factors for asthma[J]. Hum Immunol, 2008, 69(12): 851-855. 被引量:1
  • 9M Li, Shang YX, Wei B, et al. The effect of substance P on asthmaticrat airway smooth muscle cell proliferation, migration, and cytoplasmic calcium concentration in vitro[J]. J Inflamm (Lond), 2011, 8(1): 18. 被引量:1
  • 10Guilbert TW, Denlinger LC. Role of infection in the development and exacerbation of asthma[J]. Expert Rev Respir Med, 2010, 4(1): 71-83. 被引量:1

同被引文献54

  • 1陆伟珍.中药穴位敷贴对哮喘病人细胞因子IL-4 IL-10及IL-13的影响[J].辽宁中医杂志,2007,34(2):129-130. 被引量:32
  • 2陆权,陆敏.肺炎支原体感染的流行病学[J].实用儿科临床杂志,2007,22(4):241-243. 被引量:315
  • 3Zeitlinger M, Wagner CC, Heiniseh B. Ketolides-the modern relatives ofmacrolides: the pharmacokinetic perspective[J]. Clin Pharmacokinet, 2009, 48(1) : 23-38. 被引量:1
  • 4Tsiodras S, Kelesidis I, Kelesidis T, et al. entral nervous system manifestaions of Mycoplasma pneumoniae infections[J]. J Infect, 2005, 51(5) : 343-354. 被引量:1
  • 5Azuma A, Kudoh S. Diffuse panbronchiolitis in East Asia [J]. Respirol, 2006, 11(3): 249-261. 被引量:1
  • 6Arnold FW, SummersgiU JT, LaJoie AS, et al. A world- wide perspective of atypical pathogens in community-ac- quired pneumonia. Am J Respir Crit Care Med, 2007,175 (10) : 1086-1093. 被引量:1
  • 7Zeitlinger M, Wagner CC, Heiniseh B. Ketolides-the mod- em relatives of macrolides: the pharmacokinetic perspec- tive. Clin Pharmacokinet, 2009,48 ( 1 ) : 23-38. 被引量:1
  • 8Waites KB. What's new in diagnostic testing and treatment approaches Myscoplasma pneumoniae infections in chil- dren. Adv Exp Med Boil, 2011,749:47-57. 被引量:1
  • 9Furuhas K, Shirai T, Suda T, et al. Inflammatory markers in active pulmonary tuberculosis association with Thl/Th2 and Tc 1/Tc2 balance. Kekkaku, 2012,87 ( 1 ) : 1-7. 被引量:1
  • 10Kadota J, Mukae H, Ishii H, et al. Long-term efficacy and safety of clarithromycin treatment in patients with dif- fuse panbronchiolitis. Respir Med, 2003,97 (7) : 844-850. 被引量:1

引证文献8

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部